pomalidomide (pomalyst) Report issue

Small molecule Orphan Drug FDA Approved FDA Fast Track FDA Accelerated Approval FDA Priority Review FDA
AACT ChEMBL DrugBank Drug Central Drugs@FDA MeSH PubChem repoDB
Back

Drug Pricing Summary

AUS PBS

$387.6500

VA Big4

$568.9248 - $608.4845

VA FSS

$800.7576 - $800.7579

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
pomalidomide 1 mg (CAPSULE) $580.5152 VA Big4
  • Pomalyst (21)
    		•  Celgene Corporation
    pomalidomide 1 mg (CAPSULE) $608.4845 VA Big4
  • Pomalyst (100)
    		•  Celgene Corporation
    pomalidomide 1 mg (CAPSULE) $800.7576 VA FSS
  • Pomalyst (21)
    		•  Celgene Corporation
    pomalidomide 1 mg (CAPSULE) $800.7579 VA FSS
  • Pomalyst (100)
    		•  Celgene Corporation
    pomalidomide 2 mg (CAPSULE) $575.0862 VA Big4
  • Pomalyst (21)
    		•  Celgene Corporation
    pomalidomide 2 mg (CAPSULE) $603.3754 VA Big4
  • Pomalyst (100)
    		•  Celgene Corporation
    pomalidomide 2 mg (CAPSULE) $800.7576 VA FSS
  • Pomalyst (21)
    		•  Celgene Corporation
    pomalidomide 2 mg (CAPSULE) $800.7579 VA FSS
  • Pomalyst (100)
    		•  Celgene Corporation
    pomalidomide 3 mg (CAPSULE) $387.6500 AUS PBS generic
  • Pomalyst (21)
    		•  Celgene Pty Limited
    pomalidomide 3 mg (CAPSULE) $574.2600 VA Big4
  • Pomalyst (21)
    		•  Celgene Corporation
    pomalidomide 3 mg (CAPSULE) $604.7544 VA Big4
  • Pomalyst (100)
    		•  Celgene Corporation
    pomalidomide 3 mg (CAPSULE) $800.7576 VA FSS
  • Pomalyst (21)
    		•  Celgene Corporation
    pomalidomide 3 mg (CAPSULE) $800.7579 VA FSS
  • Pomalyst (100)
    		•  Celgene Corporation
    pomalidomide 4 mg (CAPSULE) $387.6500 AUS PBS generic
  • Pomalyst (21)
    		•  Celgene Pty Limited
    pomalidomide 4 mg (CAPSULE) $568.9248 VA Big4
  • Pomalyst (21)
    		•  Celgene Corporation
    pomalidomide 4 mg (CAPSULE) $604.4898 VA Big4
  • Pomalyst (100)
    		•  Celgene Corporation
    pomalidomide 4 mg (CAPSULE) $800.7576 VA FSS
  • Pomalyst (21)
    		•  Celgene Corporation
    pomalidomide 4 mg (CAPSULE) $800.7579 VA FSS
  • Pomalyst (100)
    		•  Celgene Corporation

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue